ImmuPharma PLC has become one of the notable healthcare movers on 25 August 2026, with LSE:IMM rising 17.03%.
Verici Dx plc has become one of the more closely watched small-cap healthcare stocks as investors increasingly assess its transition from a diagnostics developer into a commercially active healthcare business.
Solvonis Therapeutics has become a major small-cap healthcare stock to watch on25 August 2026 after LSE:SVNS declined 10.71%.
Shield Therapeutics (LSE:STX), the AIM-listed specialty pharmaceutical company behind the oral iron-deficiency treatment ACCRUFeR, fell 3.09% to 4.70p on 24 August 2026, according to market data. The decline came onVolumeof 1.43 million shares, a relative volume of 0.54, leaving the company with aMarket Capitalisationof …
Poolbeg Pharma (LSE:POLB), the Dublin-headquartered clinical-stage biotech listed on AIM, fell 3.41% to 8.50p on 24 August 2026, according to available market data of the day's UK biggest losers, onVolumeof 3.09 million shares against a relative volume of 1.08 — close to the stock's …
Oxford BioMedica (LSE:OXB), the Oxford-based cell and gene therapy contract development and manufacturing organisation (CDMO), fell 3.23% to 509p on 24 August 2026, putting it among the day's biggest London-listed decliners per available market data. The stock carries no meaningful trailing price/earnings ratio — …
Shares in ImmuPharma plc (LSE:IMM), the AIM-listed biopharmaceutical company developing treatments for autoimmune disease and diabetes, fell 14.66% to 3.405p on 24 August 2026, according to the market-data provider’s "Biggest losers in the United Kingdom" snapshot, onVolumeof 1.37 million shares. The fall values the …
Shares in Probiotix Health Plc (LSE:PBX), the cholesterol-lowering and cardiometabolic supplement ingredientsBusinessspun out of OptiBiotix Health, fell 14.57% to 9.35p on 24 August 2026, according to the the market-data provider’s "Biggest losers in the United Kingdom" snapshot, on volume of 10,050 shares. The move …
Haleon shares rose1.85% on 24 August 2026, closing at approximately369.80p. The gain came as investors continued to digest the company's first-half results and assess whether improving margins can compensate for relatively modest top-line growth.
Pearson shares rose2.47% on 24 August 2026, closing at around1,225p. The move came after the company had already attracted significant investor attention following its strong first-half performance and continued progress in digital education.